TREATMENT OF ALZHEIMERS-DISEASE - MOLECULAR PATHOLOGY VERSUS NEUROTRANSMITTER-BASED THERAPY

[1] BOWEN DM, 1988, ETIOLOGY DEMENTIA AL, P165

[2] THE AMYLOID PROTEINS OF ALZHEIMERS-DISEASE AS POTENTIAL TARGETS FOR DRUG-THERAPY [J]. NEUROBIOLOGY OF AGING, 1989, 10 (05) : 451 - 461

[3] A QUANTITATIVE STUDY OF THE NEUROFIBRILLARY TANGLES AND THE CHOLINE-ACETYLTRANSFERASE ACTIVITY IN THE CEREBRAL-CORTEX AND THE AMYGDALA IN ALZHEIMERS-DISEASE [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (02) : 161 - 165

[4] TACRINE, A DRUG WITH THERAPEUTIC POTENTIAL FOR DEMENTIA - POST-MORTEM BIOCHEMICAL-EVIDENCE [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1989, 16 (04) : 504 - 510

[5] GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P618, DOI 10.1016/0197-4580(89)90153-X

[6] D-CYCLOSERINE - A LIGAND FOR THE N-METHYL-D-ASPARTATE COUPLED GLYCINE RECEPTOR HAS PARTIAL AGONIST CHARACTERISTICS [J]. NEUROSCIENCE LETTERS, 1989, 98 (01) : 91 - 95

[7] CORTICOTROPIN-RELEASING FACTOR IMMUNOREACTIVE NEURONS PERSIST THROUGHOUT THE BRAIN IN ALZHEIMERS-DISEASE [J]. BRAIN RESEARCH, 1989, 501 (02) : 392 - 396

[8] GAMMA-AMINOBUTYRIC ACID CONCENTRATION IN BRAIN-TISSUE AT 2 STAGES OF ALZHEIMERS-DISEASE [J]. BRAIN, 1988, 111 : 785 - 799

[9] LOWE SL, 1990, IN PRESS NEUROSCIENC

[10] MARTIN JB, 1988, AGING BRAIN, P129

[1] BOWEN DM, 1988, ETIOLOGY DEMENTIA AL, P165

[2] THE AMYLOID PROTEINS OF ALZHEIMERS-DISEASE AS POTENTIAL TARGETS FOR DRUG-THERAPY [J]. NEUROBIOLOGY OF AGING, 1989, 10 (05) : 451 - 461

[3] A QUANTITATIVE STUDY OF THE NEUROFIBRILLARY TANGLES AND THE CHOLINE-ACETYLTRANSFERASE ACTIVITY IN THE CEREBRAL-CORTEX AND THE AMYGDALA IN ALZHEIMERS-DISEASE [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (02) : 161 - 165

[4] TACRINE, A DRUG WITH THERAPEUTIC POTENTIAL FOR DEMENTIA - POST-MORTEM BIOCHEMICAL-EVIDENCE [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1989, 16 (04) : 504 - 510

[5] GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P618, DOI 10.1016/0197-4580(89)90153-X

[6] D-CYCLOSERINE - A LIGAND FOR THE N-METHYL-D-ASPARTATE COUPLED GLYCINE RECEPTOR HAS PARTIAL AGONIST CHARACTERISTICS [J]. NEUROSCIENCE LETTERS, 1989, 98 (01) : 91 - 95

[7] CORTICOTROPIN-RELEASING FACTOR IMMUNOREACTIVE NEURONS PERSIST THROUGHOUT THE BRAIN IN ALZHEIMERS-DISEASE [J]. BRAIN RESEARCH, 1989, 501 (02) : 392 - 396

[8] GAMMA-AMINOBUTYRIC ACID CONCENTRATION IN BRAIN-TISSUE AT 2 STAGES OF ALZHEIMERS-DISEASE [J]. BRAIN, 1988, 111 : 785 - 799

[9] LOWE SL, 1990, IN PRESS NEUROSCIENC

[10] MARTIN JB, 1988, AGING BRAIN, P129